Evidence map›Paper›PMID 41141280›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Molecular chaperone effects on recombinant yield and binding characteristics of an ABA-specific scFv in

Shimiao Chen, Bin Shan, Yican Luo, Ganhui Mo, Usman Rasheed, Lilan Lv, Xinyu Yang, Qinyu Lu

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antimicrobial Effect of Silver Nanoparticles Capped withNanomaterials (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shimiao ChenKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.
Bin ShanKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.
Yican LuoKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.
Ganhui MoKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.
Usman RasheedKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.
Lilan LvKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.
Xinyu YangCollege of Food and Quality Engineering, Nanning University, Nanning, China.
Qinyu LuKey Laboratory, Guangxi Subtropical Crops Research Institute, Nanning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Recombinant single-chain variable fragments (scFvs) are promising antibody formats for cost-effective and scalable production. However, their soluble expression in Escherichia coli is often limited by misfolding and aggregation, particularly for scFvs targeting small molecule haptens such as abscisic acid (ABA). To address this bottleneck, molecular chaperones can be co-expressed to enhance folding efficiency and functional yield. Methods: An ABA-specific scFv was expressed in E. coli BL21(DE3) using five different chaperone plasmids (pG-KJE8, pGro7, pKJE7, pG-Tf2, and pTf16). Soluble expression was quantified by His-tag ELISA, and protein identity was confirmed by SDS-PAGE and Western blot. Functional characterization included competitive ELISA for IC Results: Trigger Factor (pTf16) significantly improved soluble scFv yield (19.65%) compared to the control (14.20%). The pKJE7 system achieved the highest sensitivity with the lowest IC Discussion: This study highlights that molecular chaperone choice influences both structural fidelity and functional performance of ABA-scFv in E. coli. While pKJE7 favors high sensitivity, pTf16 yields highly specific and structurally stable antibodies. These findings establish a practical basis for developing low-cost ABA immunoassays with tailored performance for agricultural biotechnology.

Indexed as

ABA-scFvantibody specificityEscherichia colimolecular chaperonesoluble expression

Identifiers

PMID41141280
PMCPMC12547695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.